Circulating APRIL levels are correlated with advanced disease and prognosis in rectal cancer patients

about

APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment.

P2860

Q37035836-D5E5DD3E-B0B0-4408-94F4-679D736CEBC7

P2860

Circulating APRIL levels are correlated with advanced disease and prognosis in rectal cancer patients

Item

http://www.wikidata.org/entity/Q41082092

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Circulating APRIL levels are c ...... osis in rectal cancer patients

@en

type

Item

label

Circulating APRIL levels are c ...... osis in rectal cancer patients

@en

prefLabel

Circulating APRIL levels are c ...... osis in rectal cancer patients

@en

P1476

Circulating APRIL levels are c ...... osis in rectal cancer patients

@en

P2093

C Röeder

http://www.w3.org/2001/XMLSchema#string

C Schafmayer

http://www.w3.org/2001/XMLSchema#string

H Kalthoff

http://www.w3.org/2001/XMLSchema#string

H van Eenennaam

http://www.w3.org/2001/XMLSchema#string

J P Medema

http://www.w3.org/2001/XMLSchema#string

K Cameron

http://www.w3.org/2001/XMLSchema#string

L Driessen

http://www.w3.org/2001/XMLSchema#string

L Papon

http://www.w3.org/2001/XMLSchema#string

M Hahne

http://www.w3.org/2001/XMLSchema#string

V Lascano

http://www.w3.org/2001/XMLSchema#string

P2860

TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation

APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth

Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum

APRIL is overexpressed in cancer: link with tumor progression

APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling

The TNF family member APRIL promotes colorectal tumorigenesis

A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth.

An APRIL to remember: novel TNF ligands as therapeutic targets.

Identification of proteoglycans as the APRIL-specific binding partners.

Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas.

P2888

oncsis.2014.50

P304

e136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONCSIS.2014.50

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272738623

http://www.w3.org/2001/XMLSchema#string

P6179

1035867387

http://www.w3.org/2001/XMLSchema#string

P698

25622308

http://www.w3.org/2001/XMLSchema#string

P932

5520648

http://www.w3.org/2001/XMLSchema#string

Circulating APRIL levels are correlated with advanced disease and prognosis in rectal cancer patients

about

P2860

P2860

Circulating APRIL levels are correlated with advanced disease and prognosis in rectal cancer patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932